The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.

In the randomized, placebo-controlled, physician-blinded Canadian cooperative trial of cyclophosphamide and plasma exchange, neither active treatment regimens (group I: i.v. cyclophosphamide and prednisone; group II: weekly plasma exchange, oral cyclophosphamide, and prednisone) were superior to pla...

詳細記述

書誌詳細
主要な著者: Noseworthy, J, Ebers, G, Vandervoort, M, Farquhar, R, Yetisir, E, Roberts, R
フォーマット: Journal article
言語:English
出版事項: 1994